2021 annual financial data
Monte Rosa Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -72,882,000 USD and net income was -73,958,000 USD.
Operating cash flow was -59,363,000 USD.
Get free Monte Rosa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -72,882,000 USD
- Net income
- -73,958,000 USD
- Operating cash flow
- -59,363,000 USD